US4301159A
Expired / Lapsed
US
⏱️ 0.0 years remaining
N-(Diethylaminoethyl)-2-alkoxy-benzamide derivatives
Assignee: SHINONOGI & Co Ltd FUKUSHIMA-KU OSAKA 553 JAPAN
•
Filing: 1980-06-20
•
Granted: 1981-11-17
•
Expires: 2000-06-20
Abstract
Abstract A compound of the formula: ##STR1## wherein R is alkyl; R 1 is hydrogen, halogen, alkyl or alkoxy; R 2 is amino, alkanoyl, ##STR2## R 3 is alkyl or dialkylamino; and R 4 is hydrogen or alkyl with the proviso that when R 2 is amino or alkanoyl, R 1 is alkyl and or a pharmaceutically acceptable acid addition salt thereof, being useful as gastric disorder remedies or antiemetics are provided via several routes.
Inventors
- 👤 Masaru Ogata
- 👤 Hiroshi Matsumoto
- 👤 Katsumi Hirose
- 👤 Masami Eigyo
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 12:48
CPC Classifications
C; C07; C07C; C07C233/00; C07C233/01; C07C233/12; C07C311/00; C07C311/01; C07C311/02
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
67 words
A compound of the formula: ##STR17## wherein R is C 1 -C 5 alkyl; R 1 is hydrogen, halogen, C 1 -C 5 alkyl or C 1 -C 5 alkoxy; R 2 is ##STR18## R 3 is C 1 -C 5 alkyl or C 2 -C 10 dialkylamino, and R 4 is hydrogen or C 1 -C 5 alkyl or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim
67 words
A compound of the formula: ##STR17## wherein R is C 1 -C 5 alkyl; R 1 is hydrogen, halogen, C 1 -C 5 alkyl or C 1 -C 5 alkoxy; R 2 is ##STR18## R 3 is C 1 -C 5 alkyl or C 2 -C 10 dialkylamino, and R 4 is hydrogen or C 1 -C 5 alkyl or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
8 words
A compound according to claim 1, namely N-(diethylaminoethyl)-5-ethanesulfonamido-2-methoxy-3-methylbenzamide.
Claim 4
Dependent Claim
8 words
A compound according to claim 1, namely N-(diethylaminoethyl)-5-methanesulfonamido-2-methoxy-3-methylbenzamide.
Claim 5
Dependent Claim
30 words
A pharmaceutical composition for treating patients suffering from gastric disorders comprising an amount of the compound of claim 1 effective for treating gastric disorders and pharmaceutical carriers, diluents, and/or adjuvants.
Claim 6
Dependent Claim
21 words
A method for treating patients suffering from gastric disorders which comprises administering to said patients a pharmaceutical composition of claim 4.
References Cited (Backward Citations)
US2691025A
Cited
US3177252A
Cited
US3219528A
Cited
US3357978A
Cited
US3591634A
Cited
US3700719A
Cited
US3739030A
Cited
US3892802A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-11-16 | 1985-05-18 | 1985-11-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-11-16 | 1989-05-18 | 1989-11-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-11-16 | 1993-05-18 | 1993-11-17 | $7700.00 | Window Closed / Lapsed |